CYCN
NASDAQ · Biotechnology
Cyclerion Therapeutics Inc
$34.98
+1.77 (+5.33%)
Open$34.37
Previous Close$33.21
Day High$34.99
Day Low$30.80
52W High$59.36
52W Low$7.19
Volume—
Avg Volume49.6K
Market Cap1.45B
P/E Ratio—
EPS$-1.68
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
-37.8% upside
Current
$34.98
$34.98
Target
$21.77
$21.77
$14.42
$21.77 avg
$30.48
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 27.08M | 24.99M | 1.11M |
| Net Income | -46,069,791 | -38,263,946 | -131,808 |
| Profit Margin | -170.1% | -161.6% | -11.8% |
| EBITDA | -47,739,618 | -41,853,670 | -161,572 |
| Free Cash Flow | — | — | -153,109 |
| Rev Growth | +8.4% | +8.4% | +14.6% |
| Debt/Equity | — | — | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |